Appelbaum, 2009, Hematopoietic cell transplantation for adult acute myeloid leukemia., Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, 4th ed., 761, 10.1002/9781444303537.ch53
Sorror, 2007, Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation., J Clin Oncol, 25, 4246, 10.1200/JCO.2006.09.7865
Koreth, 2009, Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials., JAMA, 301, 2349, 10.1001/jama.2009.813
Lee, 2007, High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation., Blood, 110, 4576, 10.1182/blood-2007-06-097386
Petersdorf, 2001, Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation., N Engl J Med, 345, 1794, 10.1056/NEJMoa011826
Kollman, 2001, Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age., Blood, 98, 2043, 10.1182/blood.V98.7.2043
Caligiuri, 2008, Human natural killer cells., Blood, 112, 461, 10.1182/blood-2007-09-077438
Biron, 1989, Severe herpesvirus infections in an adolescent without natural killer cells., N Engl J Med, 320, 1731, 10.1056/NEJM198906293202605
Ljunggren, 1990, In search of the ‘missing self’: MHC molecules and NK cell recognition., Immunol Today, 11, 237, 10.1016/0167-5699(90)90097-S
Shum, 2002, Conservation and variation in human and common chimpanzee CD94 and NKG2 genes., J Immunol, 168, 240, 10.4049/jimmunol.168.1.240
Wagtmann, 1995, Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains., Immunity, 2, 439, 10.1016/1074-7613(95)90025-X
Uhrberg, 1997, Human diversity in killer cell inhibitory receptor genes., Immunity, 7, 753, 10.1016/S1074-7613(00)80394-5
Colonna, 1995, Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells., Science, 268, 405, 10.1126/science.7716543
Valiante, 1997, Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors., Immunity, 7, 739, 10.1016/S1074-7613(00)80393-3
Ruggeri, 2002, Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants., Science, 295, 2097, 10.1126/science.1068440
Giebel, 2003, Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors., Blood, 102, 814, 10.1182/blood-2003-01-0091
Davies, 2002, Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor., Blood, 100, 3825, 10.1182/blood-2002-04-1197
Parham, 2005, MHC class I molecules and KIRs in human history, health and survival., Nat Rev Immunol, 5, 201, 10.1038/nri1570
Shilling, 2002, Genetic control of human NK cell repertoire., J Immunol, 169, 239, 10.4049/jimmunol.169.1.239
Wilson, 2000, Plasticity in the organization and sequences of human KIR/ILT gene families., Proc Natl Acad Sci U S A, 97, 4778, 10.1073/pnas.080588597
Cooley, 2009, Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia., Blood, 113, 726, 10.1182/blood-2008-07-171926
Stringaris, 2010, Donor KIR genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukaemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukaemia but not other haematological malignancies., Biol Blood Marrow Transplant, 16, 1257, 10.1016/j.bbmt.2010.03.004
Symons, 2010, Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation., Biol Blood Marrow Transplant, 16, 533, 10.1016/j.bbmt.2009.11.022
Houtchens, 2007, High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles., Immunogenetics, 59, 525, 10.1007/s00251-007-0222-x
McQueen, 2007, Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation., Hum Immunol, 68, 309, 10.1016/j.humimm.2007.01.019
Yawata, 2002, Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family., Crit Rev Immunol, 22, 463, 10.1615/CritRevImmunol.v22.i5-6.70
Martin, 2004, Comparative genomic analysis, diversity and evolution of two KIR haplotypes A and B., Gene, 335, 121, 10.1016/j.gene.2004.03.018
Klein, 2007, Analyzing survival curves at a fixed point in time., Stat Med, 26, 4505, 10.1002/sim.2864
Klein, 2003, Survival Analysis: Techniques for Censored and Truncated Data, 10.1007/b97377
Ringden, 2009, The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation., Blood, 113, 3110, 10.1182/blood-2008-07-163212
Winter, 1998, Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition., J Immunol, 161, 571, 10.4049/jimmunol.161.2.571
Stewart, 2005, Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors., Proc Natl Acad Sci U S A, 102, 13224, 10.1073/pnas.0503594102
Moesta, 2008, Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3., J Immunol, 180, 3969, 10.4049/jimmunol.180.6.3969
Yawata, 2008, MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response., Blood, 112, 2369, 10.1182/blood-2008-03-143727
Brodin, 2009, NK cell education: not an on-off switch but a tunable rheostat., Trends Immunol, 30, 143, 10.1016/j.it.2009.01.006
Khakoo, 2004, HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection., Science, 305, 872, 10.1126/science.1097670
Hou, 2007, Seventeen novel alleles add to the already extensive KIR3DL3 diversity., Tissue Antigens, 70, 449, 10.1111/j.1399-0039.2007.00930.x
Jones, 2006, Nature of allelic sequence polymorphism at the KIR3DL3 locus., Immunogenetics, 58, 614, 10.1007/s00251-006-0130-5
Lundqvist, 2007, Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donors., Blood, 109, 3603, 10.1182/blood-2006-05-024315
Russell, 2002, Lymphocyte-mediated cytotoxicity., Annu Rev Immunol, 20, 323, 10.1146/annurev.immunol.20.100201.131730
Siefer, 1993, Activated natural killer cells and interleukin-2 promote granulocytic and megakaryocytic reconstitution after syngeneic bone marrow transplantation in mice., Blood, 82, 2577, 10.1182/blood.V82.8.2577.2577
Hsu, 2006, KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy., Biol Blood Marrow Transplant, 12, 828, 10.1016/j.bbmt.2006.04.008
Leung, 2004, Determinants of antileukemia effects of allogeneic NK cells., J Immunol, 172, 644, 10.4049/jimmunol.172.1.644
Bishara, 2004, The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD., Tissue Antigens, 63, 204, 10.1111/j.0001-2815.2004.00182.x
Lowe, 2003, T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell–depleted HLA-non-identical paediatric bone marrow transplantation., Br J Haematol, 123, 323, 10.1046/j.1365-2141.2003.04604.x
Farag, 2006, The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry., Biol Blood Marrow Transplant, 12, 876, 10.1016/j.bbmt.2006.05.007
Chen, 2006, Activating KIR genes are associated with CMV reactivation and survival after non-T-cell–depleted HLA-identical sibling bone marrow transplantation for malignant disorders., Bone Marrow Transplant, 38, 437, 10.1038/sj.bmt.1705468
Hsu, 2005, Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes., Blood, 105, 4878, 10.1182/blood-2004-12-4825
Cook, 2004, The impact of donor KIR and patient HLA-C genotypes on outcome after HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia., Blood, 103, 1521, 10.1182/blood-2003-02-0438
Venstrom, 2010, Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation., Blood, 115, 3162, 10.1182/blood-2009-08-236943